Head to head

Elite iQ vs Elite MPX (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $85k–$115k for Elite iQ. No new-price range is on file for Elite MPX. Check the source notes and request current quotes.
Practice fit: Both are listed under dual-wavelength platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Dual-wavelength platform

View full device profile →

Device B

Dual-wavelength platform

View full device profile →

Price comparison

Price comparison: Cynosure Elite iQ vs Cynosure Elite MPX
Attribute	Cynosure Elite iQ	Cynosure Elite MPX
New price range	$85k–$115kSource not documented	Not published
Used asking range	$45k–$70kSource not documented	$15k–$30kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step		Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Cynosure Elite iQ: $85k–$115kSource not documented
Cynosure Elite MPX: Not published

Used asking range

Cynosure Elite iQ: $45k–$70kSource not documented
Cynosure Elite MPX: $15k–$30kSource not documented

Payback calculator

Cynosure Elite iQ: View ROI calculator
Cynosure Elite MPX: View ROI calculator

Next step

Cynosure Elite iQ

Cynosure Elite MPX

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Consumable economics

Consumable economics: Cynosure Elite iQ vs Cynosure Elite MPX
Attribute	Cynosure Elite iQ	Cynosure Elite MPX
Consumable cost / lock-in	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.	—
Service cost	Not published	Not published

Consumable cost / lock-in

Cynosure Elite iQ: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Cynosure Elite MPX: —

Service cost

Cynosure Elite iQ: Not published
Cynosure Elite MPX: Not published

FDA clearance

FDA clearance: Cynosure Elite iQ vs Cynosure Elite MPX
Attribute	Cynosure Elite iQ	Cynosure Elite MPX
FDA status & indication	FDA ClearedK193426, K240396 Read FDA indication wording “755nm: The Elite iQ laser is indicated for stable long-term or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 or 12 months after the completion of a treatment regime. It is used for skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. 1064nm: The Elite iQ laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, leg veins, spider veins and poikiloderma of Civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigines (age spots), solar lentigines (sunspots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, 755 nm: The Cynosure Elite+ Laser is indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowting when measured 6, 9, or 12 months after the completion of a treatment regime. It is used for all skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. 1064 nm: The Cynosure Elite+ Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic 755mn laser: Temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6,9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I - VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles.”	FDA ClearedK090235 Read FDA indication wording “Elite MPX 755 nm: The Elite MPX Laser system is indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hair regrowth after a treatment regime. It is used for all skin types (Fitzpatrick I-IV) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. Elite MPX 1064 nm: The Elite MPX laser system is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, leg veins, spider veins, and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), café au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. Additionally, the laser is indicated for the removal of unwanted hair, for the stable long-term, or permanent, hair reduction through selective targeting of melanin in the hair follicles, and for the treatment of pseudofolliculitis (PFB). XPL Handpiece: The XPL Pulsed Light handpiece is intended for permanent hair reduction and the treatment of dermatological vascular lesions, facial and leg veins, benign pigmented lesions, and inflammatory acne.”

FDA status & indication

Cynosure Elite iQ: FDA ClearedK193426, K240396
Read FDA indication wording
“755nm: The Elite iQ laser is indicated for stable long-term or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 or 12 months after the completion of a treatment regime. It is used for skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. 1064nm: The Elite iQ laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, leg veins, spider veins and poikiloderma of Civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigines (age spots), solar lentigines (sunspots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, 755 nm: The Cynosure Elite+ Laser is indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowting when measured 6, 9, or 12 months after the completion of a treatment regime. It is used for all skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. 1064 nm: The Cynosure Elite+ Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic 755mn laser: Temporary hair reduction. Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6,9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick I - VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles.”
Cynosure Elite MPX: FDA ClearedK090235
Read FDA indication wording
“Elite MPX 755 nm: The Elite MPX Laser system is indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hair regrowth after a treatment regime. It is used for all skin types (Fitzpatrick I-IV) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles. Elite MPX 1064 nm: The Elite MPX laser system is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, leg veins, spider veins, and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), café au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. Additionally, the laser is indicated for the removal of unwanted hair, for the stable long-term, or permanent, hair reduction through selective targeting of melanin in the hair follicles, and for the treatment of pseudofolliculitis (PFB). XPL Handpiece: The XPL Pulsed Light handpiece is intended for permanent hair reduction and the treatment of dermatological vascular lesions, facial and leg veins, benign pigmented lesions, and inflammatory acne.”

Which chains run each

Which chains run each: Cynosure Elite iQ vs Cynosure Elite MPX
Attribute	Cynosure Elite iQ	Cynosure Elite MPX
Chain adoption	2 recorded pairings	0 recorded pairings
Chains using it	SEV Laser(Confirmed) Foxy Box Laser + Wax Bar(Confirmed)	—
Approved reviews	0	0

Chain adoption

Cynosure Elite iQ: 2 recorded pairings
Cynosure Elite MPX: 0 recorded pairings

Chains using it

Cynosure Elite iQ: SEV Laser(Confirmed)
Foxy Box Laser + Wax Bar(Confirmed)
Cynosure Elite MPX: —

Approved reviews

Cynosure Elite iQ: 0
Cynosure Elite MPX: 0

Specs and platform

Specs and platform: Cynosure Elite iQ vs Cynosure Elite MPX
Attribute	Cynosure Elite iQ	Cynosure Elite MPX
Manufacturer	Cynosure	Cynosure
Built by (OEM)	Cynosure LLC	Cynosure LLC
Category	Dual-wavelength platform	Dual-wavelength platform
Technology	755/1064nm + Skintel melanin reader (Alexandrite)	755/1064nm with MultiPlex blending
Launch year	2020	2008
Status	Current	Discontinued
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Cynosure Elite iQ: Cynosure
Cynosure Elite MPX: Cynosure

Built by (OEM)

Cynosure Elite iQ: Cynosure LLC
Cynosure Elite MPX: Cynosure LLC

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Lumenis OptiLIGHT

IPL platform

New: —

Cutera Xeo

Multi-app platform

New: $80k–$120k

Cutera Excel HR

Dual-wavelength laser

New: $95k–$135k

InMode Triton

Triple-wavelength diode

New: $100k–$135k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.